Michelle Desler

1.2k total citations
20 papers, 935 citations indexed

About

Michelle Desler is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Michelle Desler has authored 20 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Genetics. Recurrent topics in Michelle Desler's work include Pluripotent Stem Cells Research (8 papers), CRISPR and Genetic Engineering (7 papers) and Cancer Cells and Metastasis (4 papers). Michelle Desler is often cited by papers focused on Pluripotent Stem Cells Research (8 papers), CRISPR and Genetic Engineering (7 papers) and Cancer Cells and Metastasis (4 papers). Michelle Desler collaborates with scholars based in United States and Japan. Michelle Desler's co-authors include Angie Rizzino, Janel L. Kopp, Briana D. Ormsbee, David Claassen, Phillip J. Wilder, Sunil K. Mallanna, Tamara K. Nowling, Cory T. Bernadt, Jesse L. Cox and Harini Chakravarthy and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Michelle Desler

20 papers receiving 927 citations

Peers

Michelle Desler
Benjamin A. Schwarz United States
Stephanie Brown United Kingdom
William C. Skarnes United Kingdom
Abdenour Soufi United Kingdom
Suzan Ruijtenberg Netherlands
Benjamin A. Schwarz United States
Michelle Desler
Citations per year, relative to Michelle Desler Michelle Desler (= 1×) peers Benjamin A. Schwarz

Countries citing papers authored by Michelle Desler

Since Specialization
Citations

This map shows the geographic impact of Michelle Desler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Desler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Desler more than expected).

Fields of papers citing papers by Michelle Desler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Desler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Desler. The network helps show where Michelle Desler may publish in the future.

Co-authorship network of co-authors of Michelle Desler

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Desler. A scholar is included among the top collaborators of Michelle Desler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Desler. Michelle Desler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vellichirammal, Neetha Nanoth, Yuan-De Tan, James D. Eudy, et al.. (2023). The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers. Human Genomics. 17(1). 64–64. 2 indexed citations
2.
Griess, Brandon, David Klinkebiel, Michelle Desler, et al.. (2020). Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas. Epigenetics. 15(12). 1325–1335. 17 indexed citations
3.
Cox, Jesse L., Phillip J. Wilder, Michelle Desler, & Angie Rizzino. (2012). Elevating SOX2 Levels Deleteriously Affects the Growth of Medulloblastoma and Glioblastoma Cells. PLoS ONE. 7(8). e44087–e44087. 49 indexed citations
4.
Cox, Jesse L., Sunil K. Mallanna, Briana D. Ormsbee, et al.. (2011). Banf1 is required to maintain the self-renewal of both mouse and human embryonic stem cells. Journal of Cell Science. 124(15). 2654–2665. 42 indexed citations
5.
Babayeva, Nigar D., Phillip J. Wilder, Masaaki Shiina, et al.. (2010). Structural basis of Ets1 cooperative binding to palindromic sequences on stromelysin-1 promoter DNA.. PubMed. 9(15). 3054–62. 27 indexed citations
6.
Babayeva, Nigar D., Phillip J. Wilder, Masaaki Shiina, et al.. (2010). Structural basis of Ets1 cooperative binding to palindromic sequences on stromelysin-1 promoter DNA. Cell Cycle. 9(15). 3126–3134. 25 indexed citations
7.
Claassen, David, Michelle Desler, & Angie Rizzino. (2009). ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells. Molecular Reproduction and Development. 76(8). 722–732. 135 indexed citations
8.
Cox, Jesse L., et al.. (2008). Regulation of the Nanog gene by both positive and negative cis‐regulatory elements in embryonal carcinoma cells and embryonic stem cells. Molecular Reproduction and Development. 76(2). 173–182. 6 indexed citations
9.
Mallanna, Sunil K., et al.. (2008). Differential regulation of the Oct‐3/4 gene in cell culture model systems that parallel different stages of mammalian development. Molecular Reproduction and Development. 75(8). 1247–1257. 8 indexed citations
10.
Chakravarthy, Harini, et al.. (2008). Identification of DPPA4 and other genes as putative Sox2:Oct‐3/4 target genes using a combination of in silico analysis and transcription‐based assays. Journal of Cellular Physiology. 216(3). 651–662. 36 indexed citations
11.
Kopp, Janel L., Briana D. Ormsbee, Michelle Desler, & Angie Rizzino. (2008). Small Increases in the Level of Sox2 Trigger the Differentiation of Mouse Embryonic Stem Cells. Stem Cells. 26(4). 903–911. 253 indexed citations
12.
Boer, Bauke de, Janel L. Kopp, Sunil K. Mallanna, et al.. (2007). Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes. Nucleic Acids Research. 35(6). 1773–1786. 95 indexed citations
13.
Bernadt, Cory T., et al.. (2006). Differential activity of the FGF‐4 enhancer in F9 and P19 embryonal carcinoma cells. Journal of Cellular Physiology. 208(1). 97–108. 14 indexed citations
14.
Kopp, Janel L., Phillip J. Wilder, Michelle Desler, Leo Kinarsky, & Angie Rizzino. (2006). Different Domains of the Transcription Factor ELF3 Are Required in a Promoter-specific Manner and Multiple Domains Control Its Binding to DNA. Journal of Biological Chemistry. 282(5). 3027–3041. 26 indexed citations
15.
Kopp, Janel L., Phillip J. Wilder, Michelle Desler, et al.. (2004). Unique and Selective Effects of Five Ets Family Members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the Promoter of the Type II Transforming Growth Factor-β Receptor Gene. Journal of Biological Chemistry. 279(19). 19407–19420. 37 indexed citations
16.
Nowling, Tamara K., et al.. (2003). The Co-activator p300 Associates Physically with and Can Mediate the Action of the Distal Enhancer of the FGF-4Gene. Journal of Biological Chemistry. 278(16). 13696–13705. 36 indexed citations
17.
Desler, Michelle, et al.. (2002). Effects of B-Myb on Gene Transcription. Journal of Biological Chemistry. 277(6). 4088–4097. 48 indexed citations
18.
Nowling, Tamara K., Michelle Desler, Charles Kuszynski, & Angie Rizzino. (2002). Transfection of embryonal carcinoma cells at high efficiency using liposome‐mediated transfection. Molecular Reproduction and Development. 63(3). 309–317. 21 indexed citations
19.
Wilder, Phillip J., Michelle Desler, Tamara K. Nowling, & Angie Rizzino. (2001). Isolation and characterization of the murine transforming growth factor-β2 promoter. Gene. 270(1-2). 201–209. 5 indexed citations
20.
Desler, Michelle, Sarah Jones, Christopher W. Smith, & Terence Woods. (1996). Effects of dexamethasone and anabolic agents on proliferation and protein synthesis and degradation in C2C12 myogenic cells.. Journal of Animal Science. 74(6). 1265–1265. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026